Experience

NEUWAY Pharma GmbH

• Germany
• Research Services
• 1 - 100 Employee

• Chief Development Officer (CDO)

  • Aug 2022 - Present



Independent Consultant

• Aachen, North Rhine-Westphalia, Germany

• Independent Consultant

  • Jun 2020 - Present

  • Pharmacology and drug discovery consultant: strategic advice on drug target validation, translational research, 3Rs animal testing, and drug development. • Neuroscience, oncology, inflammation, women's health. • Expert statements, regulatory documents, asset assessment. • Project management from LO to IND submission and beyond. NIH Heal Initiative, invited panelist at Virtual Meeting Rockville 2020 on “Target Validation for Non-Addictive Therapeutics Development for Pain”. Invitation to serve as mentor at KDDF’s 2020 “Young BD Person Workshop”. Lecture on “Translational Pain Research” and “Pre-Clinical Drug Development” at Aachen University (RWTH Excellence Cluster). Show less



Self Employed

• Aachen, North Rhine-Westphalia, Germany

• Pharma Consulting Aachen

  • Apr 2018 - Present

  Pharma Consulting Aachen was founded by Prof. Konrad Heintze and comprises expert knowledge on the complete value chain of drug development. The team is specialized in compiling drug discovery and development strategies, and experienced in reviewing, evaluation or preparation of complete preclinical documentation including expert reports. Pharma Consulting Aachen was founded by Prof. Konrad Heintze and comprises expert knowledge on the complete value chain of drug development. The team is specialized in compiling drug discovery and development strategies, and experienced in reviewing, evaluation or preparation of complete preclinical documentation including expert reports.



Grünenthal Group

• Germany
• Pharmaceutical Manufacturing
• 700 & Above Employee

• International Preclinical Project Lead

  • Apr 2018 - May 2020

  Preclinical project management of late stage projects (GLP-phase, sNDA submission). Preclinical support of PSUR/PBRER and DSUR for PV. Preclinical expert reports for regulatory submissions. Invitation by the NIH to participate in a critical review process on animal models of pain and to serve as ad-hoc reviewer for the NIH grant application on the preclinical screening platform for pain (PSPP).

• Head Pharmacology

  • 2011 - Mar 2018

  Strategic leadership of up to 30 FTEs. Development of translational strategies and biomarker capabilities for CNS and Inflammation. Implementation of 3Rs principles by human native pharmacology. Key expertise in rodent and non-rodent behavioral models. Support of the complete pharma value chain from target assessment to life-cycle management and business development. Large scientific network, contribution to and steering of pre-competitive research co-operations (BMBF, IMI, NRW-Leitmarkt, NC3R). Show less

• Lab Head Pharmacology

  • 1996 - 2011

  Project lead on several research (LO phase) and development (phase II) projects. Management of international research co-operations. Development of novel animal models of pain, inflammation and bladder function.



Hafslund Nycomed

• Linz, Austria

• Research Scientist Pharmacology

  • 1993 - 1996

  Development of in vitro (enzyme and cell-based cytokine assays) and rodent in vivo (acute nociception and inflammation) assays. Contribution to several LO projects to target pain, inflammation, bladder dysfunction, and hair growth. Development of in vitro (enzyme and cell-based cytokine assays) and rodent in vivo (acute nociception and inflammation) assays. Contribution to several LO projects to target pain, inflammation, bladder dysfunction, and hair growth.